Health Catalyst, Inc. (NASDAQ:HCAT) Receives $10.60 Average Target Price from Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have been assigned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $10.20.

Several equities analysts have recently issued reports on HCAT shares. Piper Sandler lowered their price target on Health Catalyst from $12.00 to $8.00 and set an “overweight” rating on the stock in a research report on Tuesday. Stephens raised their target price on Health Catalyst from $7.00 to $9.00 and gave the company an “equal weight” rating in a research note on Thursday, November 14th. KeyCorp upgraded shares of Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 price target on the stock in a research report on Wednesday, January 8th. Canaccord Genuity Group reduced their price objective on shares of Health Catalyst from $11.00 to $10.00 and set a “buy” rating for the company in a research report on Tuesday, January 21st. Finally, Wells Fargo & Company dropped their target price on shares of Health Catalyst from $13.00 to $10.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st.

Insider Activity

In other Health Catalyst news, insider Linda Llewelyn sold 6,442 shares of Health Catalyst stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $7.88, for a total transaction of $50,762.96. Following the transaction, the insider now directly owns 98,702 shares in the company, valued at approximately $777,771.76. The trade was a 6.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Kevin Lee Freeman sold 7,500 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $8.94, for a total transaction of $67,050.00. Following the sale, the insider now directly owns 236,950 shares in the company, valued at approximately $2,118,333. This trade represents a 3.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 81,169 shares of company stock worth $629,068 over the last 90 days. 2.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Health Catalyst

A number of institutional investors have recently bought and sold shares of the business. Quantbot Technologies LP purchased a new stake in shares of Health Catalyst in the fourth quarter worth approximately $29,000. Quest Partners LLC acquired a new position in Health Catalyst in the 3rd quarter valued at approximately $34,000. nVerses Capital LLC purchased a new stake in Health Catalyst in the 3rd quarter worth approximately $59,000. Stoneridge Investment Partners LLC acquired a new stake in shares of Health Catalyst during the 4th quarter valued at $77,000. Finally, Martin Worley Group purchased a new position in shares of Health Catalyst during the 4th quarter valued at $78,000. 85.00% of the stock is currently owned by institutional investors and hedge funds.

Health Catalyst Price Performance

NASDAQ HCAT opened at $5.44 on Friday. Health Catalyst has a 12 month low of $5.32 and a 12 month high of $10.14. The firm has a market capitalization of $331.02 million, a PE ratio of -4.03 and a beta of 1.34. The company’s 50 day simple moving average is $6.69 and its 200 day simple moving average is $7.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.